Milestone Pharmaceuticals Holds Annual Shareholder Meeting
Milestone Pharmaceuticals, Inc. convened its 2026 Annual Meeting of Shareholders today, utilizing a virtual online platform to facilitate engagement with its global investor base. Joseph Oliveto, Chief Executive Officer, President, and Executive Director, welcomed attendees, emphasizing the company’s commitment to shareholder interaction irrespective of geographical location.
The meeting, conducted entirely online, provided registered shareholders with the opportunity to submit questions and comments through a dedicated Q&A tab. This digital format aims to ensure continued dialogue and accessibility for all participants.
Forward-Looking Statements Disclaimer
During the proceedings and the subsequent question-and-answer session, company executives may present forward-looking statements. It is important to note that actual results could vary significantly from any forecasts, projections, estimates, expectations, or conclusions presented in these statements. Investors are advised to exercise caution and consider these potential discrepancies.
Shareholder Engagement and Compliance
David Sandoval, General Counsel and Chief Compliance Officer, outlined the protocols for the virtual meeting. He reminded participants that any personal information disclosed during the session would be considered consent to its recording, transfer, and use. Furthermore, individuals disclosing the personal information of others were required to confirm they had obtained all necessary consents prior to such disclosure. This measure ensures compliance and respect for privacy throughout the meeting.
Oliveto expressed gratitude for the shareholders’ participation, acknowledging the value of their time and input. He reiterated that the virtual format, while not in-person, still facilitates meaningful engagement, particularly during the interactive Q&A segment.
